Molecule Details
| InChIKey | RBKASMJPSJDQKY-RBFSKHHSSA-N |
|---|---|
| Canonical SMILES | C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.26 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13050 |
|---|---|
| Drug Name | Tirilazad |
| CAS Number | 110101-66-1 |
| Groups | investigational |
| ATC Codes | N07XX01 |
| Description | Tirilazad has been used in trials studying the treatment of Spinal Cord Injury. |
Categories: Antioxidants Biological Factors Central Nervous System Agents Compounds used in a research, industrial, or household setting Fused-Ring Compounds Nervous System Neuroprotective Agents Pregnanes Protective Agents Steroids
Cross-references: ChEBI: 135853 CHEMBL1630578 ChemSpider: 94673 PubChem:104903 PubChem:347829179 RxCUI: 72467 Wikipedia: Tirilazad ZINC: ZINC000043133316